Company news
Anixa Biosciences, Inc. news in 2024
Anixa Biosciences, Inc.'s news releases, calls and decks from 2024, newest first.
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
December 3, 2024
Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
November 21, 2024
Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
November 17, 2024
Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 7, 2024
Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 5, 2024
Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024
October 30, 2024
Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 27, 2024
Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial
October 14, 2024
Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development
October 6, 2024
Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
September 29, 2024
Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine
September 23, 2024
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference
September 17, 2024
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
September 2, 2024
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 25, 2024
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
July 28, 2024
Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
July 22, 2024
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
July 16, 2024
Anixa Biosciences Announces $5 Million Share Repurchase Program
July 14, 2024
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
June 23, 2024
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
May 20, 2024
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
May 7, 2024
Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
May 5, 2024
Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
April 29, 2024
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
April 17, 2024
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
March 13, 2024
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
March 10, 2024
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
February 11, 2024
Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
January 28, 2024
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
January 22, 2024
Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
January 9, 2024
Decks in 2024
- Shareholder Meeting (March 2024)
Shareholder meeting · 34 slides · Mar 22, 2024